Most Recent Annual Report
Upgrade your company profile to unlock all of your annual report content on AnnualReports.com
2019 Form 10K
Odonate Therapeutics, Inc. has reached its limit for free report views.
Work for Odonate Therapeutics, Inc.?
Claim Your Profile
Odonate Therapeutics, Inc.
About Odonate Therapeutics, Inc.
51-200 Employees
Based in San Diego, California
Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Our initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in the treatment of cancer.
- Ticker:
- ODT
- Exchange:
- NASDAQ (See More NASDAQ Companies)
- Industry:
- Biotechnology (See More Biotechnology Companies)
- Sector:
- Healthcare (See More Healthcare Companies)
